Searched for
INDIA PHARMACEUTICAL REGULATION
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...- Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
- India drawing up list of export snags in South AsiaIndia is identifying regulatory and market-access barriers in seven South Asian countries to expand exports and reach its $1-trillion targe...
- Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
- Sebi approves 6 IPOs including Mahanadi Coalfields, Veritas Finance and Sagar Defence. Check detailsSebi has granted approval for initial public offerings from six companies across various sectors. Companies like Mahanadi Coalfields and Sa...
- Cancer drug prices revised from today; patients may save Rs 3,540 crore annuallyThe government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit tra...
- Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Stop the price scam in our hospitalsA recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV i...
- Cancer drug prices fell in 2019 too, but mark-ups of up to 700% are backThe government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicine...
- India wants more factories, fabs and data centres. Where will the water come from?India's ambition to become a developed nation by 2047 is constrained by growing water resource challenges. Industries across sectors, inclu...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Maharashtra FDA suspends 19 food licences; acts against Patanjali distributor over 'adulteration'In a recent operation, the Maharashtra FDA suspended licenses of 19 food business operators for violations. They seized food articles worth...
- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsHere’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spe...
- Stocks in news: Infosys, Kotak Mahindra Bank, YES Bank, Raymond, BPCL, Coforge and Senco GoldIndian equity markets have faced a decline for four consecutive sessions, with the Nifty falling significantly. Various factors, including ...
- India to remain strict on quality: Industry minister Piyush GoyalIndia's Commerce Minister Piyush Goyal emphasised a strict stance on quality and environmental regulations. He noted that many companies ar...
- GDHS 2026 to focus on implementing AI actionScheduled for 20-21 November 2026, the Global Digital Health Summit will take place in New Delhi, highlighting the role of artificial intel...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
Load More
